Added value of rapid respiratory syndromic testing at point of care versus central laboratory testing: a controlled clinical trial.

Syndromic testing performed in the ED compared with the central laboratory failed to reduce the LOS or antibiotic consumption in patients with acute respiratory illness, but was associated with an increased single-room assignment among patients in whom a significant respiratory pathogen was detected.